Read More Pharma Industry News Biogen to acquire Nightstar Therapeutics in a deal worth $800m to target retinal diseases In a significant move within the biotech sector, Biogen, the US-based biotechnology giant, has announced its agreement to… bypharmanewsdailyMarch 31, 2019